California, US residents click here.
The job details are as follows:
Who We Are
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).
The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
Who You Are
The Investor Relations Analyst works under the guidance of the Head of Investor Relations to act as a liaison between the company and the public on strategy, pipeline, and financial matters. The Analyst will play a critical role in supporting communications collateral development, investment community interactions, internal communications with management, senior executives, and the board of directors, and other departmental initiatives.
- COLLATERAL DEVELOPMENT - Support the preparation and enhancement of existing communications materials, including quarterly earnings collateral, press releases, corporate presentations, FAQ documents, and product and pipeline fact sheets - Contribute to maintaining, updating, and improving the investor relations website and pipeline website - Support the development of social media content that supports investor relations activities - Collaborate with the investor relations team to prepare and develop new investor communications materials
- INVESTMENT COMMUNITY INTERACTIONS - Participate in interactions with new and existing sell-side analysts covering United Therapeutics and other biotech companies - Contribute to collecting and maintaining sell-side analyst models used to provide consensus financial data to management and external stakeholders - Monitor company-specific and industry-wide sell-side research, including scientific content, and track and provide updates on changes in peer performance - Help develop and support an active investor relations calendar, including the planning, logistics, and execution of investor conferences, investor events, non-deal roadshows, and other communication events - Assist with scheduling investor calls and meetings and provide support for and participate in meetings with institutional investors - Work with external vendors and the IR team to support efforts to target new institutional investors - Collaborate with the investor relations team to implement a sell-side and institutional investor outreach program and benchmark the program against peer activities
- INTERNAL INTERACTIONS - Support the preparation of background information for key internal spokespeople in advance of meetings with investors and other external stakeholders - Monitor industry and competitor newsflow and provide relevant updates to the investor relations team - Collaborate with key subject matter experts within the company to understand activities that may be relevant for communication to external stakeholders - Maintain and update the Investor Relations Quarterly Report distributed to senior executives and the board of directors - Track company stock performance and valuation relative to peer companies
- DEPARTMENTAL INITIATIVES - Help prepare the IR team for investor, analyst, and internal meetings - Maintain the investor relations customer relationship management (CRM) tool - Contribute to the development and implementation of external corporate communication strategies that support current business goals and objectives in collaboration with company stakeholders - Evaluate current processes within the Investor Relations department and make recommendations for improvements, benchmarking IR activities against those of current and aspirational peers
- Perform all other duties as assigned
Minimum Requirements
- Bachelor’s Degree in business, communications, or sciences
- 2+ years of relevant experience in biotech, capital markets, investor relations, FP&A, communications, or securities analysis with a Bachelor's Degree or 0+ years of relevant experience in biotech, capital markets, investor relations, FP&A, communications, or securities analysis with a Master's Degree
- Strong interpersonal skills, intellectual curiosity, and effective verbal and written communication abilities, with the ability to build positive working relationships and convey information clearly to team members and stakeholders
- Ability to receive, incorporate, and grow from real-time feedback and constructive criticism, demonstrating a commitment to continuous learning and professional development
- Energetic, efficient, and resourceful team player and individual contributor with a strong desire to learn, develop new skills, and expand knowledge within the field
- Strong attention to detail with the ability to manage multiple assignments and meet deadlines while effectively navigating incomplete, evolving, or ambiguous information with appropriate guidance when needed
- Solid working knowledge of financial modeling and valuation techniques used by securities analysts to assess a company’s operating and financial performance and support investment-related analysis
Preferred Qualifications
- Master’s Degree in business, communications, or sciences
- 1+ years of prior public company investor relations experience, sell side experience, or operational roles within other biotech companies
- Proficiency in Microsoft Office Suite, including Excel, PowerPoint, and Word; familiarity with investor relations and financial intelligence platforms such as Bloomberg, FactSet, S&P Global/Ipreo, and Workiva
Job Location
This position will be located in our RTP, NC office of United Therapeutics. Currently this job is a hybrid role requiring at least three days per week in the office. In office requirements could increase based on business needs.
At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.
Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.
Skills Required
- Bachelor's degree in business, communications, or sciences
- 2+ years relevant experience in biotech, capital markets, investor relations, FP&A, communications, or securities analysis (0+ years acceptable with Master's)
- Strong interpersonal, verbal, and written communication skills
- Ability to receive and act on feedback and commit to continuous learning
- Energetic, efficient, resourceful team player and individual contributor with desire to learn
- Strong attention to detail and ability to manage multiple assignments and deadlines
- Solid working knowledge of financial modeling and valuation techniques used by securities analysts
- Master's degree in business, communications, or sciences
- 1+ years prior public company investor relations experience, sell-side experience, or operational biotech roles
- Proficiency with Microsoft Office (Excel, PowerPoint, Word) and familiarity with Bloomberg, FactSet, S&P Global/Ipreo, Workiva
United Therapeutics Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about United Therapeutics and has not been reviewed or approved by United Therapeutics.
-
Healthcare Strength — Coverage breadth is positioned as comprehensive with the employer paying most medical, dental, and vision premiums, alongside telehealth, EAP, FSAs, and wellness initiatives. Fertility support is emphasized through full IVF coverage.
-
Parental & Family Support — Paid parental leave for all parents with additional time for birthing parents, plus adoption and surrogacy assistance, lactation rooms, and milk‑shipping indicate robust family support. Subsidized onsite childcare is available at key campuses and broader family solutions are offered through a national provider.
-
Strong & Reliable Incentives — Annual cash bonus opportunities are a consistent part of total rewards, complemented by equity eligibility and an employee stock purchase plan. Feedback suggests these incentives are widely available across many roles.
United Therapeutics Insights
What We Do
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. We currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! Our employees can be found collaborating across the United States, Europe and Asia. As a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #WeAreUnitherians






